title: Generation and characterization of a mouse single-chain antibody fragment specific for disialoganglioside (GD2).
abstract: Anti-disialoganglioside (GD2) monoclonal antibodies (MAbs) have been used in vivo for immunolocalization and in phase I and II trials to target disseminated neuroblastoma, the most common extracranial solid tumor in children. However, the efficacy of these first-generation MAbs is likely to be improved by using engineered anti-GD2 antibodies. The generation of single-chain antibody fragments (scFv) could be very helpful as these molecules can be further modified to produce recombinant molecules with pre-defined properties such as immunotoxins, chimeric, or bispecific antibodies. Thus, a scFv directed against GD2 (scFv 7A4) was cloned, sequenced, and expressed. Its binding properties were characterized and compared to that of the parental MAb 7A4. Nucleotide sequence analysis of the scFv 7A4 indicated that its VH region belongs to the V region IIID subgroup and the V kappa to the V region II subgroup. The scFv 7A4 bound to GD2+ neuroblastoma cell lines but not to GD2- cell lines or to GD2- cells isolated from peripheral blood. ELISA and thin-layer chromatography (TLC) indicated that it retained the anti-GD2 specificity, and exhibited a slight cross-reaction with GD3 as the parental MAb. This scFv makes it possible to develop new useful reagents through genetic engineering for adjuvant tumor therapy.
authors.affiliation: Laboratoire de Biotechnologie des Anticorps, Institut Curie, Paris, France.
authors.forename: S
authors.initials: S
authors.lastname: Moutel
authors.forename: S
authors.initials: S
authors.lastname: Birkle
authors.forename: V
authors.initials: V
authors.lastname: Laurence
authors.forename: J
authors.initials: J
authors.lastname: Michon
authors.forename: W H
authors.initials: WH
authors.lastname: Fridman
authors.forename: J
authors.initials: J
authors.lastname: Aubry
authors.forename: J L
authors.initials: JL
authors.lastname: Teillaud
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal / Q000235:genetics / Q000276:immunology*; D000918:Antibody Specificity; D001483:Base Sequence; D003001:Cloning, Molecular; D003429:Cross Reactions; D019084:Fluorescent Antibody Technique, Indirect; D005732:Gangliosides / Q000276:immunology*; D006801:Humans; D006825:Hybridomas; D007128:Immunoglobulin Fragments / Q000235:genetics / Q000276:immunology*; D007135:Immunoglobulin Variable Region / Q000235:genetics / Q000276:immunology*; D051379:Mice; D008969:Molecular Sequence Data; D009447:Neuroblastoma / Q000276:immunology; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000276:immunology; D016415:Sequence Alignment; D017422:Sequence Analysis, DNA; D014407:Tumor Cells, Cultured
chemical_list: D000911:Antibodies, Monoclonal; D005732:Gangliosides; D007128:Immunoglobulin Fragments; D007135:Immunoglobulin Variable Region; D011993:Recombinant Fusion Proteins; C019403:ganglioside, GD2